The Bleiswijk facility represents Thermo Fisher Scientific’s latest advancements in the cutting-edge world of cell and gene therapy. This state-of-the-art facility has been purposefully designed to support the growing number of clinical trials taking place throughout Europe and is the exclusive center of excellence and innovation hub for cell and gene therapies within the European Union.
Our Bleiswijk, Netherlands facility is a strategic expansion of our broad global network, seamlessly integrating with our other sites to foster an industry-leading synergy of expertise and resources. Its strategic proximity to international air and seaports facilitates the seamless flow of talent, technology, and therapies across borders. Welcome to the future of healthcare, nestled in the heart of Bleiswijk.
The 5,000-square-meter, state-of-the-art facility features flexible biorepository storage configurations, cold and ultracold temperature packaging, labeling and kitting suites, and robust risk mitigation strategies to enable operational efficiencies.
Capabilities for clinical and commercial cold chain material management
- Clinical trial services including storage, distribution, packaging, labeling, and qualified person (QP) release
- Commercial cell and gene therapy services - packaging, distribution, and serialization
- GMP material storage and distribution from ambient to liquid nitrogen (LN2) temperature ranges
- Just-in-time packaging for Clinical and Commercial
